Short- and Medium-term Safety/Effectiveness Analysis of Low Energy Holmium Laser Enucleation of the Prostate (HoLEP)
- Conditions
- Diseases of the genitourinary system
- Registration Number
- KCT0005154
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
HoLEP surgery using a LP laser device with an energy of less than 30 W used less total delivered energy and showed significant improvement in surgical outcomes up to 6 months follow-up. There was no difference between the HP device system in efficiency or safety.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 83
? A man over 50 years old
? Who is decided holmium laser surgery for benign prostatic hyperplasia
? A patient who has a full understanding and agreement with the study
? Patients with neurological diseases that can adversely affect urinary function (Parkinson's disease, dementia, etc.)
? Patients suffering from acute urinary retention within the last month
? Patients with urinary infection symptom
? In case there are factors that can have a significant effect on the results of treatment based on the judgement of the other researchers
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, International Prostate Symptom Score(IPSS), Uroflowmetry(UFM), Postvoid Residual Volume(PRV)
- Secondary Outcome Measures
Name Time Method Safety, Complications, Adverse events